PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,5-dinitrotoluene | 210-566-2 | 618-85-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 3,5-dinitrobenzoyl chloride | 202-750-6 | 99-33-2 | - | - | - | - | 1 | - | - | - | - | Details |
| 3,5-dinitrobenzoic acid | 202-751-1 | 99-34-3 | - | - | - | - | 1 | - | - | - | - | Details |
| 3,5-dimethylpyrazole | 200-657-5 | 67-51-6 | 1 | - | 3 | - | 1 | 1 | - | - | - | Details |
| 3,5-dimethylpiperidine | 252-730-6 | 35794-11-7 | - | - | - | - | 1 | - | - | - | - | Details |
| 3,5-dimethyl-1,2-dioxolane-3,5-diol | 237-438-9 | 13784-51-5 | - | - | 3 | - | - | - | - | - | - | Details |
| 3,5-diamino-4-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-2-[[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]benzoic acid sodium salt | 480-890-9 | 906532-68-1 | - | - | 1 | - | - | - | - | - | - | Details |
| 3,5-di(undecan-2-yl)dihydro-1H-[1,3]oxazolo[3,4-c][1,3]oxazole | 700-210-9 | 1001161-63-2 | - | - | 2 | - | - | - | - | - | - | Details |
| 3,5-bis{1-[4-(propan-2-yl)phenyl]propan-2-yl}dihydro-1H-[1,3]oxazolo[3,4-c][1,3]oxazole | 700-207-2 | 1001164-15-3 | - | - | 1 | - | - | - | - | - | - | Details |
| 3,5,5-trimethylhexyl acetate | 261-245-9 | 58430-94-7 | - | - | 3 | - | - | - | - | - | - | Details |